Lawson Kroeker Investment Management’s AbbVie ABBV Stock Holding History

Lawson Kroeker Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442K	Sell	1,758 -10	-0.6%	-$2.15K	0.12%	47
2026 Q1	$385K	Hold	1,768	–	–	0.11%	49
2025 Q4	$404K	Sell	1,768 -2,982	-63%	-$679K	0.12%	51
2025 Q3	$1.1M	Sell	4,750 -900	-16%	-$183K	0.2%	63
2025 Q2	$1.05M	Hold	5,650	–	–	0.2%	64
2025 Q1	$1.18M	Hold	5,650	–	–	0.22%	62
2024 Q4	$1M	Hold	5,650	–	–	0.19%	63
2024 Q3	$1.12M	Sell	5,650 -109	-2%	-$20.3K	0.2%	62
2024 Q2	$988K	Hold	5,759	–	–	0.19%	64
2024 Q1	$1.05M	Sell	5,759 -113	-2%	-$19.5K	0.2%	63
2023 Q4	$910K	Sell	5,872 -45	-0.8%	-$6.56K	0.19%	64
2023 Q3	$882K	Hold	5,917	–	–	0.19%	65
2023 Q2	$797K	Sell	5,917 -200	-3%	-$29.3K	0.19%	62
2023 Q1	$975K	Buy	6,117 +2,504	+69%	+$383K	0.22%	65
2022 Q4	$584K	Hold	3,613	–	–	0.2%	45
2022 Q3	$485K	Hold	3,613	–	–	0.17%	50
2022 Q2	$553K	Sell	3,613 -130	-3%	-$19.9K	0.19%	49
2022 Q1	$607K	Sell	3,743 -25	-0.7%	-$3.63K	0.19%	46
2021 Q4	$510K	Sell	3,768 -3	-0.1%	-$354	0.16%	50
2021 Q3	$407K	Hold	3,771	–	–	0.14%	53
2021 Q2	$425K	Sell	3,771 -50	-1%	-$5.63K	0.13%	55
2021 Q1	$414K	Hold	3,821	–	–	0.14%	52
2020 Q4	$409K	Hold	3,821	–	–	0.15%	52
2020 Q3	$335K	Hold	3,821	–	–	0.15%	57
2020 Q2	$375K	Hold	3,821	–	–	0.18%	53
2020 Q1	$291K	Hold	3,821	–	–	0.16%	56
2019 Q4	$338K	Hold	3,821	–	–	0.12%	59
2019 Q3	$289K	Hold	3,821	–	–	0.11%	59
2019 Q2	$278K	Hold	3,821	–	–	0.09%	60
2019 Q1	$308K	Hold	3,821	–	–	0.11%	60
2018 Q4	$352K	Sell	3,821 -100	-3%	-$8.79K	0.14%	52
2018 Q3	$371K	Hold	3,921	–	–	0.12%	57
2018 Q2	$363K	Sell	3,921 -300	-7%	-$29.3K	0.13%	58
2018 Q1	$400K	Sell	4,221 -25	-0.6%	-$2.75K	0.13%	60
2017 Q4	$411K	Sell	4,246 -300	-7%	-$28.3K	0.13%	60
2017 Q3	$404K	Hold	4,546	–	–	0.13%	61
2017 Q2	$330K	Buy	4,546 +106	+2%	+$7.13K	0.11%	63
2017 Q1	$289K	Hold	4,440	–	–	0.1%	67
2016 Q4	$278K	Hold	4,440	–	–	0.1%	66
2016 Q3	$280K	Hold	4,440	–	–	0.09%	64
2016 Q2	$275K	Hold	4,440	–	–	0.09%	64
2016 Q1	$254K	Hold	4,440	–	–	0.09%	70
2015 Q4	$263K	Sell	4,440 -6,500	-59%	-$374K	0.09%	70
2015 Q3	$595K	Sell	10,940 -450	-4%	-$29.3K	0.2%	56
2015 Q2	$765K	Hold	11,390	–	–	0.23%	61
2015 Q1	$667K	Hold	11,390	–	–	0.19%	62
2014 Q4	$745K	Hold	11,390	–	–	0.23%	54
2014 Q3	$658K	Hold	11,390	–	–	0.2%	55
2014 Q2	$643K	Hold	11,390	–	–	0.19%	59
2014 Q1	$585K	Hold	11,390	–	–	0.18%	60
2013 Q4	$602K	Hold	11,390	–	–	0.19%	58
2013 Q3	$509K	Sell	11,390 -150	-1%	-$6.65K	0.17%	60
2013 Q2	$477K	Buy	+11,540	New	+$505K	0.17%	62

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Lawson Kroeker Investment Management's ABBV Position: Q2 2026 in Review

Lawson Kroeker Investment Management reduced its AbbVie (ABBV) stake by 0.57% in Q2 2026, selling an estimated $2.15K and leaving 1,758 shares worth $442K. The position accounts for 0.12% of the portfolio, ranked #47.

Lawson Kroeker Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.18M in Q1 2025. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lawson Kroeker Investment Management held 1,758 shares of AbbVie worth $442K as of Q2 2026.
Lawson Kroeker Investment Management sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
AbbVie made up 0.12% of Lawson Kroeker Investment Management's portfolio in Q2 2026, its #47 holding.
Lawson Kroeker Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Lawson Kroeker Investment Management's AbbVie position peaked at $1.18M in Q1 2025.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.